Motilal Oswal BSE Healthcare ETF vs SBI Healthcare Opportunities Fund
Motilal vs SBI· Portfolio Overlap Analysis
56.9%High Overlap
26 common stocksRank #6060 / 20,000
Investor takeaway: At 56.9% overlap, a significant part of these portfolios is identical. Despite coming from different AMCs, the stock picks still converge heavily. Make sure both funds actually serve different jobs in your allocation.
Common Holdings (26)
| Stock | Wt% in Motilal Oswal BSE Healthcare E | Wt% in SBI Healthcare Opportunities | Overlap |
|---|---|---|---|
Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology | 13.46% | 10.65% | 10.65% |
Divi's Laboratories Limited Pharmaceuticals & Biotechnology | 5.99% | 7.55% | 5.99% |
Apollo Hospitals Enterprise Limited Healthcare Services | 5.86% | 5.76% | 5.76% |
Max Healthcare Institute Limited Healthcare Services | 5.92% | 4.82% | 4.82% |
Lupin Limited Pharmaceuticals & Biotechnology | 4.09% | 4.23% | 4.09% |
Torrent Pharmaceuticals Limited Pharmaceuticals & Biotechnology | 3.34% | 4.25% | 3.34% |
Fortis Healthcare Limited Healthcare Services | 3.60% | 3.24% | 3.24% |
Laurus Labs Limited Pharmaceuticals & Biotechnology | 3.06% | 3.48% | 3.06% |
Alkem Laboratories Limited Pharmaceuticals & Biotechnology | 2.42% | 2.77% | 2.42% |
Biocon Limited Pharmaceuticals & Biotechnology | 2.04% | 3.59% | 2.04% |
Mankind Pharma Limited Pharmaceuticals & Biotechnology | 1.84% | 2.98% | 1.84% |
Krishna Institute Of Medical Sciences Limited Healthcare Services | 1.36% | 2.92% | 1.36% |
Aster DM Healthcare Limited Healthcare Services | 1.12% | 3.85% | 1.12% |
Gland Pharma Limited Pharmaceuticals & Biotechnology | 1.06% | 2.68% | 1.06% |
Abbott India Limited Pharmaceuticals & Biotechnology | 1.03% | 1.95% | 1.03% |
Sai Life Sciences Limited Pharmaceuticals & Biotechnology | 1.00% | 1.96% | 1.00% |
Ajanta Pharma Limited Pharmaceuticals & Biotechnology | 0.93% | 1.84% | 0.93% |
Acutaas Chemicals Limited Pharmaceuticals & Biotechnology | 0.82% | 4.77% | 0.82% |
Pfizer Limited Pharmaceuticals & Biotechnology | 0.56% | 0.37% | 0.37% |
Cohance Lifesciences Limited Pharmaceuticals & Biotechnology | 0.36% | 0.91% | 0.36% |
Poly Medicure Limited Healthcare Equipment & Supplies | 0.36% | 1.97% | 0.36% |
Vijaya Diagnostic Centre Limited Healthcare Services | 0.36% | 0.62% | 0.36% |
Jupiter Life Line Hospitals Limited Healthcare Services | 0.34% | 2.79% | 0.34% |
Concord Biotech Limited Pharmaceuticals & Biotechnology | 0.30% | 2.16% | 0.30% |
Sanofi Consumer Healthcare India Limited Pharmaceuticals & Biotechnology | 0.22% | 0.83% | 0.22% |
Gufic Biosciences Limited Pharmaceuticals & Biotechnology | 0.06% | 0.69% | 0.06% |
Unique to Motilal Oswal BSE Healthcare E
- Dr. Reddy's Laboratories Limited5.75%
- Cipla Limited5.59%
Unique to SBI Healthcare Opportunities
All top holdings are shared with the other fund.
Sector Overlap Breakdown
Pharmaceuticals & Biotechnology39.6% (18)
Healthcare Services17.0% (7)
Healthcare Equipment & Supplies0.4% (1)
More comparisons for Motilal Oswal BSE Healthcare E
- vs Mirae Asset Nifty 500 Healthca88.9% · 50 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE73.4% · 20 stocks
- vs Axis NIFTY Healthcare ETF73.4% · 20 stocks
- vs DSP Nifty Healthcare ETF73.4% · 20 stocks
- vs ICICI Prudential Nifty Healthc73.4% · 20 stocks
More comparisons for SBI Healthcare Opportunities
- vs Mirae Asset Nifty 500 Healthca58.6% · 22 stocks
- vs HDFC Pharma and Healthcare54.8% · 16 stocks
- vs Mirae Asset Healthcare53.8% · 17 stocks
- vs DSP Nifty Healthcare ETF53.5% · 12 stocks
- vs ADITYA BIRLA SUN LIFE NIFTY HE53.5% · 12 stocks
Overlap calculated on equity holdings only. Debt, government securities, and cash are excluded.